期刊文献+

地依麦迪的合成工艺研究

Study on the synthesis of delamanid
原文传递
导出
摘要 目的改进抗结核药地依麦迪的合成工艺。方法 2-甲基烯丙醇经Sharpless环氧化后与对硝基苯磺酰氯反应得到中间体(R)-2-甲基环氧丙醇-4-硝基苯甲磺酸酯;N-Boc-4-羟基哌啶与对三氟甲氧基苯酚经Mitsunobu反应、脱保护、Buchwald-Hartwig反应、脱苄基得到中间体4-[4-(4-三氟甲氧基-苯氧基)哌啶基]苯酚,这两个中间体经亲核取代反应得到(R)-1-[4-(2,3-环氧-2-甲基丙氧基)苯基]-4-(4-三氟甲氧基苯氧基)哌啶,该化合物与2-溴-4-硝基咪唑经亲核取代、环合得到终产物地依麦迪。结果与结论工艺优化后,以2-甲基烯丙醇计,总收率为27.6%(优化前为17.8%),以N-Boc-4-羟基哌啶计,总收率为33.4%(优化前为11.0%),产物的HPLC化学纯度为100%,ee值也达到了100%,新工艺路线操作简单,适合工业化生产。 An optimized synthetic process to delamanid was developed. (R) -4-Nitrobenzene sulfonic acid 2-rneth- ylglycidyl (15) was prepared from 2-methallyl alcohol through Sharpless asymmetric epoxidation followed by the hydroxyl group activation with p-nitrobenzenesulfonyl chloride. 4-[ 4-(4-Trifluoromethoxyphenoxy )-piperidin-1- yll phenol(3) was synthesized from N-Boc-4-hydroxyl piperidine and p-trifluoromethoxy phenol via Mitsunobu reaction,Boc deprotection,Buchwald-Hartwig amination and benzyl deprotection. The nucleophilic substitution of 15 with 3 gave ( R )-1-(4-( ( 2-methyloxiran-2-yl ) methoxy ) phenyl )-4-(4-( trifluoromethoxy ) phenoxy ) piperi- dine,which reacted with 2-bromo-4-nitroimidazole to form the desired product(delamanid). The total yield of the process was 27.6% (based on 2-methallyl alcohol) and 33.4% ( based on N-Boc-4-hydroxyl piperidine) respectively,and the HPLC purity and ee value both reached 100%. The optimized synthetic route to delamanid was characterized with improved yield,easier operations,suitable for industrial production.
出处 《中国药物化学杂志》 CAS CSCD 2017年第3期205-209,共5页 Chinese Journal of Medicinal Chemistry
关键词 地依麦迪 合成 抗结核药 耐多药肺结核病 delamanid synthesis antituberculous drug multidrug-resistant tuberculosis
  • 相关文献

参考文献2

二级参考文献8

  • 1Lewis JM,Sloan DJ.The role of delamanid in the treatmentof drug-resistant tuberculosis[J].Ther Clin Risk Manag,2015,11:779-791.
  • 2Ryan NJ,Lo JH.Delamanid:first global approval[J].Drugs,2014,74(9):1041-1045.
  • 3Blair HA,Scott LJ.Delamanid:a review of its use in patientswith multidrug-resistant tuberculosis[J].Drugs,2015,75(1):91-100.
  • 4Goto F,Takemura N,Otani T,et al.1-Substituted-4-nitroimidazole compound and process for producing thesame:US,20060079697[P].2006-04-13.
  • 5Tsubouchi H,Haraguchi Y,Hayakawa S,et al.Epoxycompound and method for manufacturing the same:US,8552188[P].2013-10-08.
  • 6Kiyokawa H,Aki S.Method of producing aminophenolcompounds:WO,2005092832[P].2005-10-06.
  • 7Sangshetti JN,Nagawade RR,Shinde DB.Synthesis of novel3-(1-(1-substituted piperidin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-5(4H)-one as antifungal agents[J].Bioorg Med Chem Lett,2009,19(13): 3564-3567.
  • 8Sasaki H,Haraguchi Y,Itotani M,et al.Synthesis andantituberculosis activity of a novel series of optically active6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles[J].J MedChem,2007,49(26): 7854-7860.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部